The US market for stroke devices will grow strongly through 2026 as a result of the adoption of innovative devices as well as the establishment of dedicated infrastructure for stroke treatment. 

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for stroke devices in the US across a 10-year period


The results of the DAWN trial have driven expanded guidelines for the use of neurovascular thrombectomy in the treatment of AIS.

How will the updated guidelines impact market growth?

How much growth is expected in this market?

What factors limit growth of this rapidly expanding market?

An increasing number of small competitors are entering the stroke device market in the US.

How will new entrants change the competitive landscape?

What tactics are smaller companies using to gain share in the market?

Rising adoption of neurovascular thrombectomy procedures for the treatment of AIS is driving infrastructure changes for stroke care in the US.

How will these changes affect the neurovascular thrombectomy device market?

How much will infrastructure growth and change drive the stroke lab system market?

Will the focus on AIS impact interventional hemorrhagic stroke treatments?

Expansion of ICH procedure volumes hinges on obtaining conclusive clinical evidence demonstrating the superior efficacy of neurovascular evacuation devices compared to other treatment options. 

What factors will drive adoption of surgical ICH procedures and devices tailored to those procedures?

Will the reluctance of neurosurgeons to adopt new techniques and devices without strong clinical data impede this market?

How will increasing ICH treatment volumes affect the stroke device market?

Table of contents

  • United States
    • Abstract
    • Executive Summary
      • Market Highlights
      • Competitive Highlights
      • Market Developments
      • End-User Insights
      • Key Report Updates
      • Procedures Covered
      • Products Covered
    • Version History
    • Stroke Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Mergers, Acquisitions, and Partnerships
        • Product Portfolio Management
        • Pricing Strategies and Purchasing Options
        • Clinical Data
        • Physician Training and Marketing
        • Product Improvements and Innovations
      • Market Developments
    • Stroke Lab System Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Clinical Data
    • Acute Ischemic Stroke Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Pricing Strategies and Purchasing Options
        • Product Portfolio Management
        • Clinical Data
        • Physician Training and Marketing
        • Product Improvements and Innovations
    • Hemorrhagic Stroke Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Mergers, Acquisitions, and Partnerships
        • Product Portfolio Management
        • Clinical Data
        • Product Improvements and Innovations
    • Neurovascular Accessory Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Market Shares
      • Competitive Factors and Strategies
        • Product Portfolio Management
    • Appendix
      • Abbreviations
      • Bibliography

Author(s): Yang Yun Li, PhD

Yang Yun Li is an analyst within the Cardiovascular Medtech Insights team at Decision Resources Group, specializing in clot management device markets. Yang holds a in Pharmaceutical Sciences from the University of Toronto.


Related Reports

Aortic Repair Devices | Medtech 360 | Market Insights | Latin America (Supplemental)

The Latin American market for aortic repair devices will expand at a moderate rate through 2027, driven primarily by endovascular procedure volume growth and the continued developme...

View Details

Electrophysiology Mapping and Ablation Devices | Medtech 360 | Market Insights | Japan

The Japan EP mapping and ablation device market will experience moderate growth through 2027, due to favorable reimburseme...

View Details

Vascular Closure Devices | Medtech 360 | Market Insights | Global

The global VCD market will grow modestly through 2027 as a result of increasing endovascular interventional procedural volumes, and increasing clinic...

View Details

Structural Heart Closure Devices | Medtech 360 | Market Insights | Global

The global market for structural heart closure devices will grow rapidly in most countries covered through 2028, driven by strong clinical data, the availability of reimbursement, a...

View Details